---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-004977"
form_type: "8-K"
ticker: "TNGX"
cik: "0001819133"
company_name: "Tango Therapeutics, Inc."
filed_at: "2025-01-13T23:59:59+00:00"
generated_at: "2026-05-28T03:46:10.279830+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Tango Therapeutics discloses $257.9M cash as of Dec 31, 2024

## Summary
- Cash, cash equivalents and marketable securities totaled $257.9M (unaudited).
- Company updated its corporate presentation for use with investors and analysts.
- No other financial results or guidance were provided in this filing.

## SEC filing metadata
- accession: 0001193125-25-004977
- form_type: 8-K
- ticker: TNGX
- cik: 0001819133
- company_name: Tango Therapeutics, Inc.
- filed_at: 2025-01-13T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1819133/000119312525004977/0001193125-25-004977-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1819133/000119312525004977/d917886d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-004977
- JSON: https://secwatch.observer/filing/0001193125-25-004977.json
- Plain text: https://secwatch.observer/filing/0001193125-25-004977.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.